Ken Griffin Better Therapeutics, Inc. Put Options Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.34 - $1.23 $102 - $369
300 New
300 $0
Q1 2023

May 15, 2023
SELL
$0.64 - $1.45 $55,424 - $125,570
-86,600 Reduced 99.88%
100 $0
Q4 2022

Feb 14, 2023
SELL
$1.1 - $1.74 $21,450 - $33,930
-19,500 Reduced 18.36%
86,700 $95,000
Q3 2022

Nov 14, 2022
BUY
$1.53 - $2.77 $162,486 - $294,174
106,200 New
106,200 $187,000

Others Institutions Holding BTTX

# of Institutions
1
Shares Held
3K
Call Options Held
0
Put Options Held
0
View Full List

About Better Therapeutics, Inc.

BTTX Quotes by TradingView
  • Ticker BTTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,743,000
  • Description
  • Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...
More about BTTX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email